CH458337A - Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane - Google Patents
Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstaneInfo
- Publication number
- CH458337A CH458337A CH130464A CH130464A CH458337A CH 458337 A CH458337 A CH 458337A CH 130464 A CH130464 A CH 130464A CH 130464 A CH130464 A CH 130464A CH 458337 A CH458337 A CH 458337A
- Authority
- CH
- Switzerland
- Prior art keywords
- androstanes
- hydroxy
- preparation
- new substituted
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US256106A US3132160A (en) | 1963-02-04 | 1963-02-04 | 3, 11-dioxygenated-17-desoxy-5beta-androstanes and processes therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH458337A true CH458337A (de) | 1968-06-30 |
Family
ID=22971116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH130464A CH458337A (de) | 1963-02-04 | 1964-02-04 | Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane |
Country Status (5)
| Country | Link |
|---|---|
| CH (1) | CH458337A (de) |
| DE (1) | DE1242611B (de) |
| ES (1) | ES296044A1 (de) |
| FR (1) | FR3847M (de) |
| GB (1) | GB998369A (de) |
-
1963
- 1963-12-12 GB GB49166/63A patent/GB998369A/en not_active Expired
-
1964
- 1964-02-04 ES ES296044A patent/ES296044A1/es not_active Expired
- 1964-02-04 DE DEU10469A patent/DE1242611B/de active Pending
- 1964-02-04 CH CH130464A patent/CH458337A/de unknown
- 1964-04-30 FR FR973029A patent/FR3847M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB998369A (en) | 1965-07-14 |
| DE1242611B (de) | 1967-06-22 |
| ES296044A1 (es) | 1964-04-01 |
| FR3847M (fr) | 1966-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT260948B (de) | Verfahren zur Herstellung neuer, substituierter Hydroxyhydrocarbyloxyalkylsiloxane | |
| AT258302B (de) | Verfahren zur Herstellung neuer 1,2-Dihydro-1,2,4-benztriazine | |
| CH451169A (de) | Verfahren zur Herstellung neuer substituierter Phenylamino-1,3-diazacyclopentene-(2) | |
| CH441332A (de) | Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide | |
| CH459196A (de) | Verfahren zur Herstellung von 4,6-Pregnadienderivaten | |
| CH458587A (de) | Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon | |
| CH443310A (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone | |
| AT249047B (de) | Verfahren zur Herstellung neuer Benzamidobenzanilid-Derivate | |
| CH460766A (de) | Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden | |
| CH479574A (de) | Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden | |
| CH471136A (de) | Verfahren zur Herstellung neuer 1,3-Dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxyde | |
| AT280493B (de) | Verfahren zur Herstellung neuer Gona-4,9,11-triene | |
| CH505807A (de) | Verfahren zur Herstellung neuer 8,14-seco-B-Homogonane | |
| AT247848B (de) | Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen | |
| CH441583A (de) | Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen | |
| CH439328A (de) | Verfahren zur Herstellung von 3,5-Dijodthyroninen | |
| AT246741B (de) | Verfahren zur Herstellung neuer N'-substituierter N-Arylsulfonyl-harnstoffe | |
| CH458337A (de) | Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane | |
| AT244953B (de) | Verfahren zur Herstellung neuer 5-Nitro-2-furamidine | |
| CH448337A (de) | Verfahren zur Herstellung neuer 1-Amino-2-benzoyl-4-hydroxyanthrachinone | |
| AT273074B (de) | Verfahren zur Herstellung neuer 1,1-Dihydroxyphenylpropyl-3-thioäther | |
| AT250967B (de) | Verfahren zur Herstellung neuer Derivate des 1, 2-Malonyl-1, 2-dihydrocinnolins | |
| AT253703B (de) | Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden | |
| CH471056A (de) | Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden | |
| CH464174A (de) | Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid |